ESC 365 - The hyperkalaemia challenge in heart failure: what is the role of novel agents?

HFA Premium Access

The hyperkalaemia challenge in heart failure: what is the role of novel agents?

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Treatment

Session type: Satellite Symposium

Sponsored by AstraZeneca

Date: 25 May 2019

Time: 13:30 - 14:30

Session

5 presentations in this session

Chair's introduction - The hyperkalaemia challenge in heart failure: what is the role of novel agents?

Speaker: Professor A. Coats (Coventry, GB)

What is the clinical impact of hyperkalaemia?

Speaker: Professor C. Linde (Stockholm, SE)

Hyperkalaemia: a barrier to optimal management of patients with heart failure?

Speaker: Professor A. Coats (Coventry, GB)

Solving the K+ challenge in heart failure: are novel K+ binders the answer?

Speaker: Professor M. Volterrani (Rome, IT)

Clinical experience with novel K+ binders: what are the opportunities and challenges?

Speaker: Professor C. Linde (Stockholm, SE)

Speaker: Professor A. Coats (Coventry, GB)

Speaker: Professor M. Volterrani (Rome, IT)

7 speakers from this session

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)

88 presentations

4 followers

Professor Cecilia Linde

Karolinska Institutet, Stockholm (Sweden)

42 presentations

1 follower

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)

88 presentations

4 followers

Professor Maurizio Volterrani

IRCCS San Raffaele Pisana, Rome (Italy)

15 presentations

0 follower

Professor Cecilia Linde

Karolinska Institutet, Stockholm (Sweden)

42 presentations

1 follower

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)

88 presentations

4 followers

Professor Maurizio Volterrani

IRCCS San Raffaele Pisana, Rome (Italy)

15 presentations

0 follower

This platform is supported by